Module 15 - Urinary, Reproductive, Eyes, Ears and Skin medication Flashcards
Urinary analgesics - Actions and Use
- Treatment for cystitis associated with UTI’s
- Soothing effect on lining of urinary tract
Urinary analgesics - Medication type
Phenazopyridine
Phenazopyridine - Precaution
- Discontinued in Canada due to safety concerns
- Dangerous for Renal failure, liver failure and blood disorders
Urinary analgesics - Side/Adverse Effect
- Headache
- Dizziness
- Allergic reaction
- Discoloration of urine and skin
- Abdominal pain
- Vomiting
- Fever
- Chills
- Bruising/bleeding
- Dyspnea
- Tachycardia
- Seizures
Urinary analgesics - Nursing Considerations
- Vitals
- Renal function
- Allergies
- Encourage fluid intake
- Inform patient that drug can cause reddish-orange discoloration of skin
- Administer with or after meals
- Do not chew, break or crush tablets
Urinary stimulants - Actions and Use
- Cholinergic Agonist or Parasympathomimetics
- Stimulates muscarinic receptors acts on smooth muscles of urinary tract
- Improves tone of urinary muscles
Treatment: Urinary Retention (Post-op)
Urinary stimulants - Medication
Bethanechol
Urinary stimulants - Side/Adverse Effect
- GI symptoms (abdominal pain, nausea, vomiting, diarrhea)
- Headache
- Sweating
- Flushing
- Fainting
- Hypotension
- Bradycardia
Urinary stimulants - Nursing Considerations
- Renal function
- Electrolytes
- Vitals (BP)
- Monitor vital signs before and after administration
- Intake and output
- Palpate for bladder distention
- Observe for drug toxicity (sweating, flushing, abdominal cramps and nausea)
Urinary Antispasmodics/Antimuscarinics - Actions and Use
- Blocks acetylcholine and inhibit involuntary contraction of detrusor muscles
Treatment: Overactive bladder and incontinence
Urinary Antispasmodics/Antimuscarinics - Medication
Flavoxate
Urinary Antispasmodics/Antimuscarinics - Side/Adverse Effects
- Tachycardia
- Palpitations
- Eosinophilia
- Dysuria
- Blurred vision
- Drowsiness
- Nausea
- Vomiting
Women’s Health - Oral Estrogen-progestin combination contraceptives - Actions and Use
- Used to prevent pregnancy by inhibiting ovulation
- Contain a combination of estrogen and progestin
- oral contraceptive begins on day 5 of the ovarian cycle and continues for 21 days
Oral Estrogen-progestin combination contraceptives - Medication Types (3)
1) Monophasic - most common form, consistent amount of estrogen/progestin in 21 day cycle
2) Biphasic - constant dose of estrogen throughout the 21 day cycle and progestin near the end
3) Triphasic - amount of estrogen/progestin varies during 21 day cycle
Oral Estrogen-progestin combination contraceptives - Side/Adverse Effects
- Migraines
- Risk of breast cancer
- Elevated glucose
- Hypertension
- Weight gain
- Depression
- Acne
- Increased appetite
- Nausea
- Edema
- Breast tenderness
- Decreased breast milk
- Thromboembolic disorders
Oral Estrogen-progestin combination contraceptives - Nursing Considerations
- Educate on lifestyle changes (smoking, diet, exercise)
- Assess mood
- Asses skin
- Vitals (HR,BP)
- Precaution use for breast cancer clients
- Assess for long-term use
Hormone Replacement Therapy (Female)- Actions and Use
- Prevent complications associated with estrogen loss
- Mimic’s estrogen
Treatment: Unpleasant symptoms of menopause, ovary removal/hysterectomies and osteoporosis
Hormone Replacement Therapy (Female) - Side/Adverse Effects
- Stroke
- Breast cancer
- Dementia
- Venous thrombosis
Hormone Replacement Therapy (Female) - Progesterone - Action and Use
Limits and stabilize endometrium growth
- Mimic progesterone
Hormone Replacement Therapy (Female) - Progesterone -Side/Adverse Effects
- Bleeding
- Weight gain
- Depression
- Hypertension
- N/V
- Thrombolytic disease
- Photosensitivity
Hormone Replacement Therapy (Female) - Progesterone - Nursing Considerations
- Vitals
- Assess for bleeding
- Administration of a progestin in a pattern starting 5 days after the onset of menses and continuing for the next 20 days can sometimes help re-establish a normal monthly cycle
- In case of heavy bleeding, high doses of conjugated estrogen’s may be administered for 3 weeks prior to adding progesterone for the last 10 days of therapy
BPH Medication
Alpha 1 Adrenergic Blockers
ex) terazosin
Alpha 1 Adrenergic Blockers - Actions and Use
- Relax the smooth muscle in the prostate gland, urethra, and bladder neck
- Blocks Epinephrine
- Promotes Parasympathetic response
Alpha 1 Adrenergic Blockers - Side/Adverse effects
- Orthostatic hypotension
- Headache
- Dizziness
- Nausea
- Abnormal ejaculation
Alpha 1 Adrenergic Blockers - Nursing considerations
- Vitals (BP)
- Change positions
- Encourage fluid intake
- GU Assessment
- Cystoscopy
- Educate on life long management
5-Alpha Reductase Inhibitors - Actions and Use
- Converts testosterone to dihydrotestosterone (DHT)
- Enhances prostate growth
- Do not use with severe BPH
5-Alpha Reductase Inhibitors - Side/Adverse Effects
- Decreased libido
- Ejaculation dysfunction
- Impotence
- Gynecomastia
- Syncope